EX-99.2 4 l22311aexv99w2.htm EX-99.2 EX-99.2
 

EXHIBIT 99.2
ULTRALIFE BATTERIES, INC.
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS
     The following unaudited pro forma financial statements combine the historical consolidated balance sheets and statements of operations of Ultralife Batteries, Inc. (“Ultralife”) and McDowell Research, Ltd. (“McDowell”), giving effect to the acquisition of substantially all of the assets of McDowell by Ultralife on July 3, 2006 using the purchase method of accounting.
     The unaudited pro forma condensed combined statements of operations for the six months ended July 1, 2006 (June 30, 2006 for McDowell) and for the year ended December 31, 2005 are presented to give effect to the acquisition of substantially all of the assets of McDowell as if it had occurred on January 1, 2005. The unaudited pro forma condensed combined balance sheets as of July 1, 2006 (June 30, 2006 for McDowell) are presented to give effect to the acquisition of substantially all of the assets of McDowell on July 1, 2006.
     The unaudited pro forma financial statements are presented for illustrative purposes only and are not intended to represent or be indicative of the consolidated results of operations or the consolidated financial position of Ultralife that would have been reported had the acquisition been consummated as of the dates presented, and should not be viewed to be representative of future operating results or the financial position of Ultralife. The unaudited pro forma financial statements do not reflect any adjustments to conform accounting policies, other than those mentioned in the notes thereto, or to reflect any cost synergies anticipated as a result of the acquisition, or any future acquisition related expenses.
     Certain adjustments made to the unaudited pro forma financial statements have been prepared based on preliminary estimates of the fair values of the net assets from McDowell. The impact of ongoing integration activities and adjustments to the fair value of acquired net tangible and intangible assets of McDowell could cause material differences in the information presented.
     The unaudited pro forma financial statements should be read in conjunction with the historical consolidated financial statements of McDowell included in this Current Report on Form 8-K/A and the consolidated financial statements of Ultralife included in its Quarterly Report on Form 10-Q for the period ended July 1, 2006 and its Annual Report on Form 10-K for the year ended December 31, 2005.

 


 

ULTRALIFE BATTERIES, INC.
UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS
SIX MONTHS ENDED JULY 1, 2006
(Amounts In Thousands, Except Per Share Amounts)
                                         
    Historical     Pro Forma             Pro Forma  
    Ultralife     McDowell     Adjustments             Combined  
 
Revenues
  $ 39,712     $ 12,573     $ (428 )     (D)     $ 51,857  
 
                                       
Cost of products sold
    31,365       5,735       (428 )     (D)          
 
                    1,786       (G)       38,458  
 
                               
 
                                       
Gross margin
    8,347       6,838       (1,786 )             13,399  
 
                                       
Operating expenses:
                                       
Research and development
    1,844             150       (G)       1,994  
Selling, general, and administrative
    5,814       3,798       (1,936 )     (G)       7,676  
Amortization of Intangibles
                836       (B)       836  
 
                               
Total operating expenses
    7,658       3,798       (950 )             10,506  
 
                               
 
                                       
Operating income/(loss)
    689       3,040       (836 )             2,893  
 
                                       
Other income (expense):
                                       
Interest income
    85       10       (58 )     (C)       37  
Interest expense
    (412 )     (116 )     (400 )     (A)          
 
                    (91 )     (C)       (1,019 )
Gain on insurance settlment
    191                           191  
Miscellaneous
    147                           147  
 
                               
 
                                       
Income/(loss) before income taxes
    700       2,934       (1,385 )             2,249  
 
                               
 
                                       
Income tax provision/(benefit) — current
    24             998       (E)          
 
                    (575 )     (F)       447  
 
                                       
Income tax provision/(benefit) — deferred
    427                           427  
 
                               
Total income taxes
    451             423               874  
 
                               
 
                                       
Net Income/(Loss)
  $ 249     $ 2,934     $ (1,808 )           $ 1,375  
 
                               
 
                                       
Earnings/(Loss) per share — basic
  $ 0.02                             $ 0.09  
Earnings/(Loss) per share — diluted
  $ 0.02                             $ 0.09  
 
                                       
Weighted average shares outstanding — basic
    14,807                               14,807  
Weighted average shares outstanding — diluted
    15,150                               15,150  
See accompanying notes to unaudited pro forma condensed combined financial statements.

 


 

ULTRALIFE BATTERIES, INC.
UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS
YEAR ENDED DECEMBER 31, 2005
(Amounts In Thousands, Except Per Share Amounts)
                                         
    Historical     Pro Forma             Pro Forma  
    Ultralife     McDowell     Adjustments             Combined  
 
                                       
Revenues
  $ 70,501     $ 21,702     $ (1,463 )     (K)     $ 90,740  
 
                                       
Cost of products sold
    58,243       10,438       (1,463 )     (K)          
 
                    4,125       (N)       71,343  
 
                               
 
                                       
Gross margin
    12,258       11,264       (4,125 )             19,397  
 
                                       
Operating expenses:
                                       
Research and development
    3,751             1,367       (N)       5,118  
Selling, general, and administrative
    11,409       9,706       (5,492 )     (N)       15,623  
Amortization of Intangibles
                1,673       (I)       1,673  
 
                               
Total operating expenses
    15,160       9,706       (2,452 )             22,414  
 
                               
 
                                       
Operating income/(loss)
    (2,902 )     1,558       (1,673 )             (3,017 )
 
                                       
Other income (expense):
                                       
Interest income
    185       60       (106 )     (J)       139  
Interest expense
    (821 )     (219 )     (800 )     (H)          
 
                    (82 )     (J)       (1,922 )
Gain on insurance settlment
                               
Miscellaneous
    (318 )                         (318 )
 
                               
 
                                       
Income/(loss) before income taxes
    (3,856 )     1,399       (2,661 )             (5,118 )
 
                               
 
                                       
Income tax provision/(benefit) — current
    3             476       (L)          
 
                    (1,104 )     (M)       (625 )
Income tax provision/(benefit) — deferred
    486                           486  
 
                               
Total income taxes
    489             (628 )             (139 )
 
                               
 
                                       
Net Income/(Loss)
  $ (4,345 )   $ 1,399     $ (2,033 )           $ (4,979 )
 
                               
 
                                       
Earnings/(Loss) per share — basic
  $ (0.30 )                           $ (0.34 )
Earnings/(Loss) per share — diluted
  $ (0.30 )                           $ (0.34 )
 
                                       
Weighted average shares outstanding — basic
    14,551                               14,551  
Weighted average shares outstanding — diluted
    14,551                               14,551  
See accompanying notes to unaudited pro forma condensed combined financial statements.

 


 

ULTRALIFE BATTERIES, INC.
UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET
AS OF JULY 1, 2006
(Amounts In Thousands, Except Per Share Amounts)
                                         
    Historical     Pro Forma             Pro Forma  
    Ultralife     McDowell     Adjustments             Combined  
ASSETS
                                       
 
                                       
Current assets:
                                       
Cash and cash equivalents
  $ 4,237     $ 567     $ (567 )     (O)          
 
                    (3,000 )     (P)     $ 1,237  
Trade accounts receivable, net
    12,748       4,347       (498 )     (O)          
 
                    (250 )     (T)       16,347  
Inventories
    17,010       4,312                     21,322  
Deferred tax asset — current
    2,406                           2,406  
Prepaid expenses and other current assets
    1,752       667       (9 )     (O)       2,410  
 
                               
Total current assets
    38,153       9,893       (4,324 )             43,722  
 
                                       
Property, plant and equipment, net
    19,892       1,592       (947 )     (O)       20,537  
 
                                       
Goodwill and Intangible Assets
    2,806             17,567       (Q)          
 
                    3,000       (S)       23,373  
 
                                       
Other assets
                                       
Security deposits and other
    12                           12  
Deferred tax asset — non-current
    20,880                           20,880  
 
                               
 
                                       
Total Assets
  $ 81,743     $ 11,485     $ 15,296             $ 108,524  
 
                               
 
                                       
LIABILITIES AND SHAREHOLDERS’ EQUITY
                                       
 
                                       
Current liabilities:
                                       
Short-term debt and current portion of long-term debt
  $ 6,190     $ 293     $ (247 )     (O)          
 
                    2,000       (P)     $ 8,236  
Accounts payable
    5,681       1,790       (7 )     (O)          
 
                    58       (P)          
 
                    (250 )     (T)       7,272  
Income taxes payable
    23                           23  
Other current liabilities
    4,168       471       (364 )     (O)          
 
                    3,000       (S)       7,275  
 
                               
Total current liabilities
    16,062       2,554       4,190               22,806  
 
                               
 
                                       
Long-term liabilities:
                                       
Debt and capital lease obligations
    25       775       (738 )     (O)          
 
                    20,000       (P)       20,062  
Other long-term liabilities
    251                           251  
 
                               
Total long-term liabilities
    276       775       19,262               20,313  
 
                               
 
                                       
Shareholders’ equity:
                                       
Common stock, par value $0.10 per share
    1,565       2       (2 )     (R)       1,565  
Capital in excess of par value
    133,159       4,820       (4,820 )     (R)       133,159  
Accumulated other comprehensive income
    (652 )                         (652 )
Retained earnings (Accumulated deficit)
    (66,289 )     3,334       (3,334 )     (R)       (66,289 )
 
                               
 
    67,783       8,156       (8,156 )             67,783  
Less — Treasury stock, at cost
    2,378                             2,378  
 
                               
Total shareholders’ equity
    65,405       8,156       (8,156 )             65,405  
 
                               
 
                                       
Total Liabilities and Shareholders’ Equity
  $ 81,743     $ 11,485     $ 15,296             $ 108,524  
 
                               
See accompanying notes to unaudited pro forma condensed combined financial statements.

 


 

ULTRALIFE BATTERIES, INC.
NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS
(Amounts in Thousands, except Share Amounts)
Note 1: Basis of Presentation and Purchase Price Allocation
     On July 3, 2006, the Company finalized the acquisition of substantially all of the assets of McDowell Research, Ltd. (“McDowell”), a manufacturer of military communications accessories located in Waco, Texas.
     Under the terms of the agreement, the purchase price of approximately $25,000 consisted of $5,000 in cash and a $20,000 non-transferable convertible note to be held by the sellers. The purchase price is subject to a post-closing adjustment based on a final valuation of trade accounts receivable, inventory and trade accounts payable that were acquired or assumed on the date of the closing, using a base value of $3,000. Ultralife Batteries, Inc. (“Ultralife”) presently estimates the net value of these assets to be approximately $6,000, resulting in a revised purchase price of approximately $28,000. The final purchase is subject to the finalization of negotiations pertaining to the valuation of trade accounts receivable, inventory and trade accounts payable. Substantial negotiations involving this valuation remain ongoing. The initial $5,000 cash portion was financed through a combination of cash on hand and borrowing through the revolver component of Ultralife’s credit facility with its primary lending banks, which was recently amended to contemplate the acquisition of McDowell. The $20,000 convertible note carries a five-year term and is convertible at $15 per share into 1.33 million shares of Ultralife’s common stock, with a forced conversion feature at $17.50 per share. The Company has incurred $58 in acquisition related costs, which are included in the approximate total cost of the investment of $28,058.
     The estimated excess of the purchase price over the net tangible and intangible assets acquired of $20,567 was recorded as goodwill in the amount of $10,027. Ultralife is in the process of completing third party valuations of certain tangible and intangible assets acquired with the new business. The final allocation of the excess of the purchase price over the net assets acquired is subject to revision based upon the third party’s valuation. The acquired goodwill will be assigned to the communications accessories segment and is expected to be fully deductible for income tax purposes.
     The following table represents the preliminary allocation of the purchase price to assets acquired and liabilities assumed at the acquisition date:
         
ASSETS
       
Current assets:
       
Trade accounts receivables, net
  $ 3,849  
Inventories
    4,312  
Prepaid inventory and other current expenses
    658  
 
     
Total current assets
    8,819  
Property, plant and equipment, net
    645  
Goodwill
    10,027  
Intangible Assets:
       
Patents and technology
    5,270  
Customer relationships
    4,392  
Non-compete agreements
    878  
 
     
Total assets acquired
    30,031  
 
     

 


 

         
LIABILITIES
       
Current liabilities:
       
Current portion of long-term debt
    46  
Accounts payable
    1,783  
Other current liabilities
    107  
 
     
Total current liabilities
    1,936  
Long-term liabilities:
       
Debt
    37  
 
     
Total liabilities assumed
    1,973  
 
     
 
       
Total Purchase Price
  $ 28,058  
 
     
     The patents and technology and customer relationships intangible assets will be amortized on a pattern in which the economic benefits of the intangible assets are being utilized over their estimated useful life of seven years. The non-compete agreements intangible asset will be amortized on a straight-line basis over its estimated useful life of three years.
Note 2: Pro Forma Adjustments
The unaudited pro forma condensed combined statements of operations include the adjustments necessary to give effect to the acquisition as if it had occurred on January 1, 2005. The unaudited pro forma condensed combined statements of operations reflect the allocation of the acquisition cost to the fair value of tangible and intangible assets acquired and liabilities assumed as described in Note 1. The unaudited pro forma condensed combined balance sheets include the adjustment necessary to give effect to the acquisition as if it occurred on July 1, 2006. No pro forma adjustments were required to conform McDowell’s accounting policies to Ultralife’s accounting policies.
(A) Adjustment to record six months of interest expense relating to the $20,000 convertible note payable issued in connection with McDowell’s acquisition purchase price, which bears interest at 4%.
(B) Adjustment to record six months of amortization expense relating to the identified intangible assets with finite lives in connection with the acquisition of McDowell.
(C) Adjustment to record six months impact on interest income that would not have been earned (at a weighted average interest rate of 4.60%) due to a lower average outstanding cash balance and the corresponding impact on interest expense that would have been incurred (at a weighted average interest rate of 7.66%) due to a higher average outstanding balance on the revolver portion of the credit facility, to fund the cash portion of McDowell’s acquisition purchase price.
(D) Adjustment to eliminate intercompany sales and purchases between Ultralife and McDowell for the six months ended.
(E) Adjustment to record income tax impact of results of operations for McDowell for the six months ended based on the applicable statutory federal income tax rate of 34%.

 


 

(F) Adjustment to record income tax impact of pro forma adjustments for the six months ended based on the applicable statutory federal and state income tax rates of 34% and 7.5%, respectively.
(G) Adjustment to reclass certain amounts in the historical McDowell financial statements to conform with Ultralife’s current presentation.
(H) Adjustment to record twelve months of interest expense relating to the $20,000 convertible note payable issued in connection with McDowell’s acquisition purchase price, which bears interest at 4%.
(I) Adjustment to record twelve months of amortization expense relating to the identified intangible assets with finite lives in connection with the acquisition of McDowell.
(J) Adjustment to record twelve months impact on interest income that would not have been earned (at a weighted average interest rate of 2.93%) due to a lower average outstanding cash balance and the corresponding impact on interest expense that would have been incurred (at a weighted average interest rate of 6.79%) due to a higher average outstanding balance on the revolver portion of the credit facility, to fund the cash portion of McDowell’s acquisition purchase price.
(K) Adjustment to eliminate intercompany sales and purchases between Ultralife and McDowell for the twelve months ended.
(L) Adjustment to record income tax impact of results of operations for McDowell for the twelve months ended based on the applicable statutory federal income tax rate of 34%.
(M) Adjustment to record income tax impact of pro forma adjustments for the twelve months ended based on the applicable statutory federal and state income tax rates of 34% and 7.5%, respectively.
(N) Adjustment to reclass certain amounts in the historical McDowell financial statements to conform with Ultralife’s current presentation.
(O) Adjustment to eliminate McDowell assets not acquired and liabilities not assumed in connection with Ultralife’s purchase of substantially all of the assets of McDowell.
(P) Adjustment to record the $5,000 cash payment, net of $2,000 in short-term borrowings, and the issuance of the $20,000 convertible note payable in connection with McDowell’s acquisition purchase price, along with the accrual of $58 in capitalized acquisition costs.
(Q) Adjustment to record the intangible assets and goodwill associated with the allocation of the McDowell acquisition purchase price.
(R) Adjustment to eliminate McDowell’s equity associated with the allocation of the McDowell acquisition purchase price.
(S) Adjustment to record the estimated post-closing adjustment to the final purchase price, based on the valuation of the net assets acquired.
(T) Adjustment to eliminate intercompany receivables and payables between Ultralife and McDowell as of July 1, 2006.